PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 26, 2026Antibiotics0 citationsOpen Access

Routine Susceptibility Testing of Helicobacter pylori in Clinical Practice—Results of a Prospective Multicentre Study

View Full Paper
AHAnke HildebrandtFWFarina WewersLULutz Uflacker

Key Points

  • The study aims to implement routine susceptibility testing for Helicobacter pylori to improve first-line antibiotic therapy and gather local resistance data.
  • Performed susceptibility testing on positive HUT samples from patients undergoing gastroscopy across two hospitals in Germany from January 2024 to April 2025.
  • Conducted both phenotypic and molecular resistance testing on cultured Helicobacter pylori samples from biopsy specimens.
  • Collected and analyzed regional antibiotic resistance patterns from the tested samples.
  • In total, 1503 patients were analyzed, with a 17% histological positivity rate for Helicobacter pylori.
  • 311 positive HUT samples were sent for susceptibility testing, with 120 samples successfully cultured.
  • Resistance rates observed included 3-33% for metronidazole, 16-20% for clarithromycin, and 13-16% for levofloxacin.

Abstract

Background/Objectives: Helicobacter pylori (HP) antibiotic eradication treatment in Germany is, at present, empirical according to the national guidelines. The aim of our prospective multicentre study was to implement routine susceptibility testing in daily clinical practice to facilitate resistance-oriented first-line antibiotic therapy and to collect local resistance data. Methods: From 1 January 2024 to 30 April 2025, in two German hospitals (in Bielefeld and Datteln), the patients who underwent gastroscopy and those who had biopsies for histopathology also underwent biopsies for the Helicobacter urease test (HUT). Positive HUT samples were sent for susceptibility testing: they were checked for phenotypic/cultural resistance to amoxicillin, clarithromycin, metronidazole, levofloxacin, rifampicin and tetracycline and genotypic/molecular resistance to clarithromycin and fluoroquinolones. Results: In total, in 1503 cases, both HUT and histology were performed, in which 256 (17.0%) histologies were HP-positive. We sent 311/1503 (20.7%) positive HUTs for susceptibility testing. In 120 (38.6%) of them, it was possible to culture HP, and for 118 cases, phenotypic resistance testing was performed. In 200/311 cases, PCR was also executed, with 111/200 cases being subjected to subsequent molecular resistance testing. Resistance patterns varied regionally, with metronidazole resistance observed in 3–33%, clarithromycin resistance in 16–20% and levofloxacin resistance in 13–16% cases. Conclusions: it is technically and logically feasible to perform HP antibiotic susceptibility testing via the same biopsy used for the HUT. The proposed procedures might be applied both in hospital and outpatient settings in endoscopic offices. Routine susceptibility testing is useful not only for the individual patient but also for monitoring the development of regional resistance patterns as a basis for better-targeted empiric therapy. Additionally, this approach might help to reduce the resistance dynamics at large in terms of antimicrobial stewardship.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hildebrandt et al. (2026) studied this question.

synapsesocial.com/papers/69edabb84a46254e215b3a73https://doi.org/10.3390/antibiotics15050426
Ask AI
Helpful
Bookmark
Share
View Full Paper